JC Polyomavirus (JCV) and monoclonal antibodies: Friends or potential foes?

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Diotti, Roberta Antonia ^a   Nakanishi, Akira ^b   Clementi, Nicola ^a   Mancini, Nicasio ^a   Criscuolo, Elena ^a   Solforosi, Laura ^a   Clementi, Massimo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGNOPROTEIN; DOUBLE STRANDED DNA; IMMUNOGLOBULIN G ANTIBODY; MONOCLONAL ANTIBODY; NATALIZUMAB; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; VERY LATE ACTIVATION ANTIGEN 4;

ANTIBODY COMBINING SITE; ANTIBODY TITER; BLOOD BRAIN BARRIER; CELL DIFFERENTIATION; CELL INFILTRATION; CYTOTOXIC T LYMPHOCYTE; DNA BINDING; DNA REPLICATION; DNA REPLICATION ORIGIN; DRUG TOLERABILITY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; GENE MUTATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTERNALIZATION; JC VIRUS; LEUKOCYTE; MICROVASCULAR ENDOTHELIAL CELL; MONOTHERAPY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RECEPTOR BINDING; REVIEW; SURVIVAL RATE; TATA BOX; VIRAL TROPISM; VIRUS ENTRY; VIRUS GENOME; VIRUS REACTIVATION; VIRUS REPLICATION; IMMUNE SYSTEM; IMMUNOLOGY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PHYSIOLOGY;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNE SYSTEM; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;

EID: 84880175176     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/967581     Document Type: Review

References (110)

1. Åström K.-E., Mancall E. L., Richardson E. P. Jr., Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958 81 1 93 111 2-s2.0-77957184066 10.1093/brain/81.1.93
2. ZuRhein G. M., Chou S.-M., Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965 148 3676 1477 1479 2-s2.0-37049239382
3. Padgett B. L., Walker D. L., ZuRhein G. M., Eckroade R. J., Dessel B. H., Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. The Lancet 1971 1 7712 1257 1260 2-s2.0-0015232447
4. Carson K. R., Focosi D., Major E. O., Petrini M., Richey E. A., West D. P., Bennett C. L., Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a review from the Research on Adverse Drug Events and Reports (RADAR) Project. The Lancet Oncology 2009 10 8 816 824 2-s2.0-67651158993 10.1016/S1470-2045(09)70161-5
5. Hogg R. S., O'Shaughnessy M. V., Gataric N., Yip B., Craib K., Schechter M. T., Montaner J. S. G., Decline in deaths from AIDS due to new antiretrovirals. The Lancet 1997 349 9061, article 1294 2-s2.0-0343742642
6. Gray F., Chrétien F., Vallat-Decouvelaere A. V., Scaravilli F., The changing pattern of HIV neuropathology in the HAART Era. Journal of Neuropathology and Experimental Neurology 2003 62 5 429 440 2-s2.0-0037651991 (Pubitemid 36560185)
7. D'Arminio Monforte A., Cinque P., Mocroft A., Goebel F.-D., Antunes F., Katlama C., Justesen U. S., Vella S., Kirk O., Lundgren J., Changing incidence of central nervous system diseases in the EuroSIDA cohort. Annals of Neurology 2004 55 3 320 328 2-s2.0-10744220788 10.1002/ana.10827 (Pubitemid 38292033)
8. Petito C. K., Cho E.-S., Lemann W., Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. Journal of Neuropathology and Experimental Neurology 1986 45 6 635 646 2-s2.0-0023026807 (Pubitemid 17181303)
9. Crowder C. D., Gyure K. A., Drachenberg C. B., Werner J., Morales R. E., Hirsch H. H., Ramos E., Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. American Journal of Transplantation 2005 5 5 1151 1158 2-s2.0-17644424311 10.1111/j.1600-6143.2005. 00800.x (Pubitemid 40571268)
10. Shitrit D., Lev N., Bar-Gil-Shitrit A., Kramer M. R., Progressive multifocal leukoencephalopathy in transplant recipients. Transplant International 2005 17 11 658 665 2-s2.0-17644428059 10.1007/s00147-004-0779-3 (Pubitemid 40558222)
11. Clifford D. B., Ances B., Costello C., Rosen-Schmidt S., Andersson M., Parks D., Perry A., Yerra R., Schmidt R., Alvarez E., Tyler K. L., Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Archives of Neurology 2011 68 9 1156 1164 2-s2.0-80052777262 10.1001/archneurol.2011.103
12. Molloy E. S., Calabrese L. H., Therapy: targeted but not trouble-free: efalizumab and PML. Nature reviews. Rheumatology 2009 5 8 418 419 2-s2.0-70349172267
13. Mountain A., Adair J. R., Engineering antibodies for therapy. Biotechnology & Genetic Engineering Reviews 1992 10 1 142 2-s2.0-0027026865
14. Ferenczy M. W., Marshall L. J., Nelson C. D., Atwood W. J., Nath A., Khalili K., Major E. O., Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clinical Microbiology Reviews 25 3 471 506
15. Vermersch P., Kappos L., Gold R., Foley J. F., Olsson T., Cadavid D., Bozic C., Richman S., Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology 2011 76 20 1697 1704 2-s2.0-79957449040 10.1212/WNL.0b013e31821a446b
16. Compston A., Making progress on the natural history of multiple sclerosis. Brain 2006 129 3 561 563 2-s2.0-33244488712 10.1093/brain/awl034 (Pubitemid 43278219)
17. Confavreux C., Vukusic S., Age at disability milestones in multiple sclerosis. Brain 2006 129 3 595 605 2-s2.0-33244469927 10.1093/brain/awh714 (Pubitemid 43278222)
18. Goldenberg M. M., Multiple sclerosis review. P & T 2012 37 3 175 184 2-s2.0-84859179884
19. Yaldizli Ö., Putzki N., Natalizumab in the treatment of multiple sclerosis. Therapeutic Advances in Neurological Disorders 2009 2 2 115 128 2-s2.0-77949486554 10.1177/1756285608101861
20. Houff S., Berger J. R., Reply to "'Thinking without thinking' about natalizumab and PML" Journal of the Neurological Sciences 2008 264 1-2 198 199 2-s2.0-36549058188 10.1016/j.jns.2007.09.019 (Pubitemid 350184090)
21. von Andrian U. H., Engelhardt B., α 4 integrins as therapeutic targets in autoimmune disease. The New England Journal of Medicine 2003 348 1 68 72 2-s2.0-0037413240 10.1056/NEJMe020157 (Pubitemid 36026351)
22. Marshall L. J., Dunham L., Major E. O., Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter/enhancer of JC virus and supports viral activity. Journal of General Virology 2010 91 12 3042 3052 2-s2.0-78650074421 10.1099/vir.0.023184-0
23. Rinaldi L., Rinaldi F., Perini P., Calabrese M., Seppi D., Grossi P., Mattisi I., Barzon L., Mengoli C., Sanzari M., Palú G., Gallo P., No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 18 month follow-up study. Journal of Neurology, Neurosurgery and Psychiatry 2010 81 12 1345 1350 2-s2.0-78649628087 10.1136/jnnp.2009.201079
24. Bloomgren G., Richman S., Hotermans C., Subramanyam M., Goelz S., Natarajan A., Lee S., Plavina T., Scanlon J. V., Sandrock A., Bozic C., Risk of natalizumab-associated progressive multifocal leukoencephalopathy. The New England Journal of Medicine 2012 366 20 1870 1880 10.1056/NEJMoa1107829
25. Diotti R. A., Sautto G. A., Solforosi L., Mancini N., Clementi M., Burioni R., Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein. The New Microbiologica 2012 35 4 475 479
26. Johne R., Buck C. B., Allander T., Atwood W. J., Garcea R. L., Imperiale M. J., Major E. O., Ramqvist T., Norkin L. C., Taxonomical developments in the family Polyomaviridae. Archives of Virology 2011 156 9 1627 1634 2-s2.0-80052273419 10.1007/s00705-011-1008-x
27. Eash S., Manley K., Gasparovic M., Querbes W., Atwood W. J., The human polyomaviruses. Cellular and Molecular Life Sciences 2006 63 7-8 865 876 2-s2.0-33646693646 10.1007/s00018-005-5454-z (Pubitemid 43731778)
28. Gardner S. D., Field A. M., Coleman D. V., Hulme B., New human papovavirus (B.K.) isolated from urine after renal transplantation. The Lancet 1971 1 7712 1253 1257 2-s2.0-0015232481
29. Sugimoto C., Hasegawa M., Kato A., Zheng H.-Y., Ebihara H., Taguchi F., Kitamura T., Yogo Y., Evolution of human polyomavirus JC: implications for the population history of humans. Journal of Molecular Evolution 2002 54 3 285 297 2-s2.0-0036175673 (Pubitemid 34165414)
30. Martin J. D., King D. M., Slauch J. M., Frisque R. J., Differences in regulatory sequences of naturally occurring JC virus variants. Journal of Virology 1985 53 1 306 311 2-s2.0-0021995514 (Pubitemid 15194972)
31. Reid C. E., Li H., Sur G., Carmillo P., Bushnell S., Tizard R., McAuliffe M., Tonkin C., Simon K., Goelz S., Cinque P., Gorelik L., Carulli J. P., Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. The Journal of Infectious Diseases 2011 204 2 237 244 2-s2.0-79958755750 10.1093/infdis/jir256
32. Tan C. S., Ellis L. C., Wüthrich C., Ngo L., Broge T. A. Jr., Saint-Aubyn J., Miller J. S., Koralnik I. J., JC virus latency in the brain and extraneural organs of patients with and without progressive multifocal leukoencephalopathy. Journal of Virology 2010 84 18 9200 9209 2-s2.0-77956044326 10.1128/JVI.00609-10
33. Prins C., Frisque R. J., JC virus T' proteins encoded by alternatively spliced early mRNAs enhance T antigen-mediated viral DNA replication in human cells. Journal of NeuroVirology 2001 7 3 250 264 2-s2.0-0034925552 10.1080/13550280152403290 (Pubitemid 32685259)
34. del Valle L., White M. K., Khalili K., Potential mechanisms of the human polyomavirus JC in neural oncogenesis. Journal of Neuropathology and Experimental Neurology 2008 67 8 729 740 2-s2.0-52249093352 10.1097/NEN. 0b013e318180e631
35. Ishaq M., Stoner G. L., Differential expression of mRNAs for JC virus large and small tumor antigens in brain tissues from progressive multifocal leukoencephalopathy patients with and without AIDS. Proceedings of the National Academy of Sciences of the United States of America 1994 91 17 8283 8287 2-s2.0-0027934850 10.1073/pnas.91.17.8283 (Pubitemid 24253931)
36. Suzuki T., Orba Y., Okada Y., Sunden Y., Kimura T., Tanaka S., Nagashima K., Hall W. W., Sawa H., The human polyoma JC virus agnoprotein acts as a viroporin. PLoS Pathogens 2010 6 3 2-s2.0-77950444850 10.1371/journal.ppat. 1000801 e1000801
37. Safak M., Barrucco R., Darbinyan A., Okada Y., Nagashima K., Khalili K., Interaction of JC virus Agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. Journal of Virology 2001 75 3 1476 1486 2-s2.0-0035152379 10.1128/JVI.75.3.1476-1486.2001 (Pubitemid 32094705)
38. Geiger R., Andritschke D., Friebe S., Herzog F., Luisoni S., Heger T., Helenius A., BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol. Nature Cell Biology 2011 13 11 1305 1314 2-s2.0-80455143829 10.1038/ncb2339
39. Inoue T., Tsai B., A large and intact viral particle penetrates the endoplasmic reticulum membrane to reach the cytosol. PLoS Pathogens 2011 7 5 2-s2.0-79958051219 10.1371/journal.ppat.1002037 e1002037
40. Nakanishi A., Shum D., Morioka H., Otsuka E., Kasamatsu H., Interaction of the Vp3 nuclear localization signal with the importin α 2/ β heterodimer directs nuclear entry of infecting simian virus 40. Journal of Virology 2002 76 18 9368 9377 2-s2.0-0036720837 10.1128/JVI.76.18.9368-9377.2002 (Pubitemid 34919894)
41. Kamen R., Favaloro J., Parker J., Topography of the three late mRNA's of polyoma virus which encode the virion proteins. Journal of Virology 1980 33 2 637 651 2-s2.0-0018874785 (Pubitemid 10176525)
42. Stehle T., Harrison S. C., High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. The EMBO Journal 1997 16 16 5139 5148 2-s2.0-0030839256 10.1093/emboj/16.16.5139 (Pubitemid 27348421)
43. Gorelik L., Reid C., Testa M., Brickelmaier M., Bossolasco S., Pazzi A., Bestetti A., Carmillo P., Wilson E., McAuliffe M., Tonkin C., Carulli J. P., Lugovskoy A., Lazzarin A., Sunyaev S., Simon K., Cinque P., Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity. The Journal of Infectious Diseases 2011 204 1 103 114 2-s2.0-79957947385 10.1093/infdis/jir198
44. Sunyaev S. R., Lugovskoy A., Simon K., Gorelik L., Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML). PLoS Genetics 2009 5 2 2-s2.0-61449209921 10.1371/journal.pgen.1000368 e1000368
45. Delbue S., Branchetti E., Bertolacci S., Tavazzi E., Marchioni E., Maserati R., Minnucci G., Tremolada S., Vago G., Ferrante P., JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy. Journal of NeuroVirology 2009 15 1 51 56 2-s2.0-61849085200 10.1080/13550280802425467
46. Dugan A. S., Eash S., Atwood W. J., An N-linked glycoprotein with α (2,3)-linked sialic acid is a receptor for BK virus. Journal of Virology 2005 79 22 14442 14445 2-s2.0-27644460490 10.1128/JVI.79.22.14442-14445.2005 (Pubitemid 41552742)
47. Neu U., Maginnis M. S., Palma A. S., Ströh L. J., Nelson C. D. S., Feizi T., Atwood W. J., Stehle T., Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host & Microbe 2010 8 4 309 319 2-s2.0-77958084582 10.1016/j.chom.2010.09.004
48. Elphick G. F., Querbes W., Jordan J. A., Gee G. V., Eash S., Manley K., Dugan A., Stanifer M., Bhatnagar A., Kroeze W. K., Roth B. L., Atwood W. J., The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004 306 5700 1380 1383 2-s2.0-8844269161 10.1126/science.1103492 (Pubitemid 39532516)
49. Wei G., Liu C. K., Atwood W. J., JC Virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes. Journal of NeuroVirology 2000 6 2 127 136 2-s2.0-0034123003 (Pubitemid 30303571)
50. Raj G. V., Khalili K., Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV. Virology 1995 213 2 283 291 2-s2.0-0028891938 10.1006/viro.1995.0001
51. Pho M. T., Ashok A., Atwood W. J., JC virus enters human glial cells by clathrin-dependent receptor- mediated endocytosis. Journal of Virology 2000 74 5 2288 2292 2-s2.0-0033968050 10.1128/JVI.74.5.2288-2292.2000 (Pubitemid 30091483)
52. Querbes W., Benmerah A., Tosoni D., Di Fiore P. P., Atwood W. J., A JC virus-induced signal is required for infection of glial cells by a clathrin- and eps15-dependent pathway. Journal of Virology 2004 78 1 250 256 2-s2.0-0347626041 10.1128/JVI.78.1.250-256.2004 (Pubitemid 37549737)
53. Feigenbaum L., Khalili K., Major E., Khoury G., Regulation of the host range of human papovavirus JCV. Proceedings of the National Academy of Sciences of the United States of America 1987 84 11 3695 3698 2-s2.0-0023279744 (Pubitemid 17088348)
54. Major E. O., History and current concepts in the pathogenesis of PML. Cleveland Clinic Journal of Medicine 2011 78 supplement 2 S3 S7 2-s2.0-84859900243
55. Clayson E. T., Brando L. V. J., Compans R. W., Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. Journal of Virology 1989 63 5 2278 2288 2-s2.0-0024600795 (Pubitemid 19107825)
56. Yogo Y., Kitamura T., Sugimoto C., Ueki T., Aso Y., Hara K., Taguchi F., Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. Journal of Virology 1990 64 6 3139 3143 2-s2.0-0025302980 (Pubitemid 20171319)
57. Brew B. J., Davies N. W. S., Cinque P., Clifford D. B., Nath A., Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nature Reviews Neurology 2010 6 12 667 679 2-s2.0-78649969090 10.1038/nrneurol.2010.164
58. Kepes J. J., Chou S. M., Price L. W. Jr., Progressive multifocal leukoencephalopathy with 10 yr survival in a patient with nontropical sprue: report of a case with unusual light and electron microscopic features. Neurology 1975 25 11 1006 1012 2-s2.0-0016801505
59. Berger J. R., Progressive multifocal leukoencephalopathy and newer biological agents. Drug Safety 2010 33 11 969 983 2-s2.0-77957777247 10.2165/11537510-000000000-00000
60. Berger J. R., Kaszovitz B., Post M. J. D., Dickinson G., Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Annals of Internal Medicine 1987 107 1 78 87 2-s2.0-0023229323 (Pubitemid 17098643)
61. Cinque P., Scarpellini P., Vago L., Linde A., Lazzarin A., Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997 11 1 1 17 2-s2.0-0031025940 10.1097/00002030-199701000-00003 (Pubitemid 27023207)
62. Major E. O., Amemiya K., Tornatore C. S., Houff S. A., Berger J. R., Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clinical Microbiology Reviews 1992 5 1 49 73 2-s2.0-0026500952
63. Atwood W. J., Amemiya K., Traub R., Harms J., Major E. O., Interaction of the human polyomavirus, JCV, with human B-lymphocytes. Virology 1992 190 2 716 723 2-s2.0-0026775246 10.1016/0042-6822(92)90909-9
64. Major E. O., Amemiya K., Elder G., Houff S. A., Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV. Journal of Neuroscience Research 1990 27 4 461 471 2-s2.0-0025606931 10.1002/jnr.490270405
65. Houff S. A., Major E. O., Katz D. A., Kufta C. V., Sever J. L., Pittaluga S., Roberts J. R., Gitt J., Saini N., Lux W., Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. The New England Journal of Medicine 1988 318 5 301 305 2-s2.0-0023860204 (Pubitemid 18034522)
66. Tavazzi E., White M. K., Khalili K., Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Reviews in Medical Virology 2012 22 1 18 32 2-s2.0-84855666303 10.1002/rmv.710
67. Marriott P. J., O'Brien M. D., MacKenzie I. C. K., Janota I., Progressive multifocal leucoencephalopathy: remission with cytarabine. Journal of Neurology Neurosurgery and Psychiatry 1975 38 3 205 209 2-s2.0-0016822328
68. Major E. O., Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annual Review of Medicine 2010 61 35 47 2-s2.0-77949375380 10.1146/annurev.med.080708.082655
69. Haider S., Nafziger D., Gutierrez J. A., Brar I., Mateo N., Fogle J., Progressive multifocal leukoencephalopathy and idiopathic CD4+lymphocytopenia: a case report and review of reported cases. Clinical Infectious Diseases 2000 31 4 E20 E22 2-s2.0-18044393264
70. Albrecht H., Hoffmann C., Degen O., Stoehr A., Plettenberg A., Mertenskötter T., Eggers C., Stellbrink H.-J., Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998 12 10 1149 1154 2-s2.0-0032499933 10.1097/00002030-199810000-00006 (Pubitemid 28302416)
71. Engsig F. N., Hansen A.-B. E., Omland L. H., Kronborg G., Gerstoft J., Laursen A. L., Pedersen C., Mogensen C. B., Nielsen L., Obel N., Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. The Journal of Infectious Diseases 2009 199 1 77 83 2-s2.0-58749083385 10.1086/595299
72. Perkins M. R., Ryschkewitsch C., Liebner J. C., Monaco M. C., Himelfarb D., Ireland S., Roque A., Edward H. L., Jensen P. N., Remington G., Abraham T., Abraham J., Greenberg B., Kaufman C., Laganke C., Monson N. L., Xu X., Frohman E., Major E. O., Douek D. C., Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy. PLoS Pathogens 2012 8 11 e1003014
73. Lindå H., von Heijne A., Major E. O., Ryschkewitsch C., Berg J., Olsson T., Martin C., Progressive multifocal leukoencephalopathy after natalizumab monotherapy. The New England Journal of Medicine 2009 361 11 1081 1087 2-s2.0-70149111495 10.1056/NEJMoa0810316
74. Weber T., Trebst C., Frye S., Cinque P., Vago L., Sindic C. J. M., Schulz-Schaeffer W. J., Kretzschmar H. A., Enzensberger W., Hunsmann G., Luke W., Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. The Journal of Infectious Diseases 1997 176 1 250 254 2-s2.0-16944363426 (Pubitemid 27272877)
75. Clementi N., Mancini N., Solforosi L., Castelli M., Clementi M., Burioni R., Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens. International Journal of Molecular Sciences 2012 13 7 8273 8292 10.3390/ijms13078273
76. Sautto G., Mancini N., Diotti R. A., Solforosi L., Clementi M., Burioni R., Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference. Antiviral Research 2012 96 1 82 89 10.1016/j.antiviral.2012.07.013
77. Burioni R., Mancini N., Carletti S., Perotti M., Grieco A., Canducci F., Varaldo P. E., Clementi M., Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection. Virology 2004 327 2 242 248 2-s2.0-4544331326 10.1016/j.virol.2004.06.042 (Pubitemid 39213982)
78. Burioni R., Matsuura Y., Mancini N., Tani H., Miyamura T., Varaldo P. E., Clementi M., Diverging effects of human recombinant anti-hepatitis C virus (HCV) antibody fragments derived from a single patient on the infectivity of a vesicular stomatitis virus/HCV pseudotype. Journal of Virology 2002 76 22 11775 11779 2-s2.0-0036827644 10.1128/JVI.76.22.11775-11779.2002 (Pubitemid 35231335)
79. Burioni R., Mancini N., de Marco D., Clementi N., Perotti M., Nitti G., Sassi M., Canducci F., Shvela K., Bagnarelli P., Mascola J. R., Clementi M., Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site. PLoS ONE 2008 3 10, article e3423 2-s2.0-54849437925 10.1371/journal.pone.0003423
80. Mancini N., Diotti R. A., Perotti M., Sautto G., Clementi N., Nitti G., Patel A. H., Ball J. K., Clementi M., Burioni R., Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes. PLoS ONE 2009 4 12, article e8254 2-s2.0-77949525938
81. Sautto G. A., Diotti R. A., Clementi M., New therapeutic options for HCV infection in the monoclonal antibody era. The New Microbiologica 2012 35 4 387 397
82. Solforosi L., Mancini N., Canducci F., Clementi N., Sautto G. A., Diotti R. A., Clementi M., Burioni R., A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments. The New Microbiologica 2012 35 3 289 294
83. Perotti M., Mancini N., Diotti R. A., Tarr A. W., Ball J. K., Owsianka A., Adair R., Patel A. H., Clementi M., Burioni R., Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein. Journal of Virology 2008 82 2 1047 1052 2-s2.0-37849016609 10.1128/JVI.01986-07
84. Nicasio M., Sautto G., Clementi N., Diotti R. A., Criscuolo E., Castelli M., Solforosi L., Clementi M., Burioni R., Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape? Viruses 2012 4 9 1731 1752 10.3390/v4091731
85. Clifford D. B., Yiannoutsos C., Glicksman M., Simpson D. M., Singer E. J., Piliero P. J., Marra C. M., Francis G. S., McArthur J. C., Tyler K. L., Tselis A. C., Hyslop N. E., Haart improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999 52 3 623 625 2-s2.0-0033017386 (Pubitemid 29075615)
86. Khatri B. S., Byrne K., Kawakami M., Brockwell D. J., Smith D. A., Radford S. E., McLeish T. C. B., Internal friction of single polypeptide chains at high stretch. Faraday Discussions 2008 139 35 51 2-s2.0-50849135501 10.1039/b716418c
87. Lehmann H. C., Hartung H.-P., Hetzel G. R., Stüve O., Kieseier B. C., Plasma exchange in neuroimmunological disorders: part 1: rationale and treatment of inflammatory central nervous system disorders. Archives of Neurology 2006 63 7 930 935 2-s2.0-33745809518 10.1001/archneur.63.7.930 (Pubitemid 44036291)
88. Lehmann H. C., Hartung H.-P., Hetzel G. R., Stüve O., Kieseier B. C., Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders. Archives of Neurology 2006 63 8 1066 1071 2-s2.0-33747157912 10.1001/archneur.63.8.1066 (Pubitemid 44232310)
89. Marra C. M., Rajicic N., Barker D. E., Cohen B. A., Clifford D., Donovan Post M. J., Ruiz A., Bowen B. C., Huang M.-L., Queen-Baker J., Andersen J., Kelly S., Shriver S., A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 2002 16 13 1791 1797 2-s2.0-18644377201 10.1097/00002030-200209060-00012
90. Hall C. D., Dafni U., Simpson D., Clifford D., Wetherill P. E., Cohen B., Mcarthur J., Hollander H., Yainnoutsos C., Major E., Millar L., Timpone J., Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. The New England Journal of Medicine 1998 338 19 1345 1351 2-s2.0-0344743110 10.1056/NEJM199805073381903 (Pubitemid 28216663)
91. Gray F., Bazille C., Adle-Biassette H., Mikol J., Moulignier A., Scaravilli F., Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. Journal of NeuroVirology 2005 11 3 16 22 2-s2.0-33645055683 10.1080/13550280500511741
92. Kappos L., Bates D., Hartung H.-P., Havrdova E., Miller D., Polman C. H., Ravnborg M., Hauser S. L., Rudick R. A., Weiner H. L., O'Connor P. W., King J., Radue E. W., Yousry T., Major E. O., Clifford D. B., Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurology 2007 6 5 431 441 2-s2.0-34047272106 10.1016/S1474-4422(07)70078-9 (Pubitemid 46551850)
93. Venkataramana A., Pardo C. A., McArthur J. C., Kerr D. A., Irani D. N., Griffin J. W., Burger P., Reich D. S., Calabresi P. A., Nath A., Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006 67 3 383 388 2-s2.0-33747039795 10.1212/01.wnl.0000227922.22293. 93 (Pubitemid 44214957)
94. Aly L., Yousef S., Schippling S., Jelcic I., Breiden P., Matschke J., Schulz R., Bofill-Mas S., Jones L., Demina V., Linnebank M., Ogg G., Girones R., Weber T., Sospedra M., Martin R., Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain 2011 134 9 2687 2702 2-s2.0-80052942855 10.1093/brain/awr206
95. Vendrely A., Bienvenu B., Gasnault J., Thiebault J. B., Salmon D., Gray F., Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathologica 2005 109 4 449 455 2-s2.0-18344386233 10.1007/s00401-005- 0983-y (Pubitemid 40637320)
96. Tan K., Roda R., Ostrow L., McArthur J., Nath A., PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids. Neurology 2009 72 17 1458 1464 2-s2.0-67549085134 10.1212/01.wnl.0000343510. 08643.74
97. Baum S., Ashok A., Gee G., Dimitrova S., Querbes W., Jordan J., Atwood W. J., Early events in the life cycle of JC virus as potential therapeutics targets for the treatment of progressive multifocal leukoencephalopathy. Journal of NeuroVirology 2003 9 supplement 1 32 37 2-s2.0-0038136785 (Pubitemid 36656468)
98. Gasnault J., Kousignian P., Kahraman M., Rahoiljaon J., Matheron S., Delfraissy J.-F., Taoufik Y., Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. Journal of NeuroVirology 2001 7 4 375 381 2-s2.0-0034828018 10.1080/13550280152537274 (Pubitemid 32894245)
99. de Luca A., Giancola M. L., Ammassari A., Grisetti S., Cingolani A., Larussa D., Alba L., Murri R., Ippolito G., Cauda R., D'Arminio Monforte A., Antinori A., Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study. Journal of NeuroVirology 2001 7 4 364 368 2-s2.0-17944369783 10.1080/13550280152537256 (Pubitemid 32894243)
100. Jiang Z.-G., Cohen J., Marshall L. J., Major E. O., Hexadecyloxypropyl- cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures. Antimicrobial Agents and Chemotherapy 2010 54 11 4723 4732 2-s2.0-78049256334 10.1128/AAC.00837-10
101. Kerr D. A., Chang C.-F., Gordon J., Bjornsti M.-A., Khalili K., Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin. Virology 1993 196 2 612 618 2-s2.0-0027430663 10.1006/viro.1993. 1517
102. Balduzzi A., Lucchini G., Hirsch H. H., Basso S., Cioni M., Rovelli A., Zincone A., Grimaldi M., Corti P., Bonanomi S., Biondi A., Locatelli F., Biagi E., Comoli P., Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient. Bone Marrow Transplantation 2011 46 7 987 992 2-s2.0-79960188497 10.1038/bmt.2010.221
103. Atwood W. J., A combination of low-dose chlorpromazine and neutralizing antibodies inhibits the spread of JC virus (JCV) in a tissue culture model: implications for prophylactic and therapeutic treatment of progressive multifocal leukencephalopathy. Journal of NeuroVirology 2001 7 4 307 310 2-s2.0-0034837329 10.1080/13550280152537157 (Pubitemid 32894233)
104. Clementi N., de Marco D., Mancini N., Solforosi L., Moreno G. J., Gubareva L. V., Mishin V., Di Pietro A., Vicenzi E., Siccardi A. G., Clementi M., Burioni R., A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS ONE 2011 6 12, article e28001 2-s2.0-82955194795 10.1371/journal.pone.0028001
105. Burioni R., Williamson R. A., Sanna P. P., Bloom F. E., Burton D. R., Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro. Proceedings of the National Academy of Sciences of the United States of America 1994 91 1 355 359 2-s2.0-0028082433 10.1073/pnas.91.1.355 (Pubitemid 24018703)
106. Burioni R., Plaisant P., Manzin A., Rosa D., Carri V. D., Bugli F., Solforosi L., Abrignani S., Varaldo P. E., Fadda G., Clementi M., Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology 1998 28 3 810 814 2-s2.0-17344364478 (Pubitemid 28405434)
107. Burioni R., Perotti M., Mancini N., Clementi M., Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs. Journal of Hepatology 2008 49 2 299 300 2-s2.0-46149124765 10.1016/j.jhep.2008. 05.008
108. Burioni R., Canducci F., Mancini N., Clementi N., Sassi M., De Marco D., Diotti R. A., Saita D., Sampaolo M., Sautto G., Pianezze M., Clementi M., Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV). Virology 2010 399 1 144 152 2-s2.0-77049088439 10.1016/j.virol.2009.12.014
109. Chandra P. K., Hazari S., Poat B., Gunduz F., Prabhu R., Liu G., Burioni R., Clementi M., Garry R. F., Dash S., Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone. Virology Journal 2010 7, article 118 2-s2.0-77953080993 10.1186/1743-422X-7-118
110. de Marco D., Clementi N., Mancini N., Solforosi L., Moreno G. J., Sun X., Tumpey T. M., Gubareva L. V., Mishin V., Clementi M., Burioni R., A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. PLoS ONE 2012 7 4, article e34415 2-s2.0-84859364851 10.1371/journal.pone.0034415